Pain Medication Recall as Dire Warning Issued

A pain-relieving injection has been recalled after a customer found white particles floating inside the vial.

The pharmaceutical company Eugia US LLC has withdrawn a batch of its Methocarbamol Injections, used to treat musculoskeletal conditions, nationwide.

Injecting something that contains particles can cause irritation or swelling at the spot where the needle has gone in, the company said in its Food and Drug Administration (FDA) announcement.

But there are more serious risks if these particles reach someone’s blood vessels and are able to travel to various organs, the agency warned.

This can “block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death,” the risk statement said.

However, Eugia US LLC stressed that, as of 22 March, the firm had not received any reports of users being harmed.

The lot being recalled has the following details:

• Methocarbamol Injection, USP 1000mg/10mL (100mg/mL), NDC code 55150-223-10, Lot# 3MC23011, Expiration Date November 2026.

This batch was distributed to wholesalers between January 12 and 16 this year, according to the pharmaceutical company.

The FDA has told wholesalers, hospitals, pharmacies and doctors to stop using the product immediately and to get in touch with anyone they have given it to.

To check if your medication might be affected, you can find these details on the enclosed vial label.

If you have taken the drug and are experiencing health problems, you should contact your physician.

Adverse reactions can also be reported to the FDA’s MedWatch Adverse Event Reporting program online, or by mail or fax.

Newsweek has contacted Eugia US LLC, of East Windsor, New Jersey, for comment.

Methocarbamol Injection is a “central nervous system depressant with sedative and musculoskeletal relaxant properties,” per the Medical Professionals Reference (MPR), a drug information resource for healthcare professionals.

The jabs are usually prescribed along with rest and physical therapy to treat conditions such as back pain, rheumatoid arthritis, gout and lupus, among others.

Musculoskeletal conditions affect more than one in two over-28s in the U.S., according to The Burden of Musculoskeletal Diseases in the United States, produced by the United States Bone and Joint Initiative (USBJI).